BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8645555)

  • 1. B-cell neoplasia in a developmental framework.
    Klein G
    Int J Dev Biol; 1995 Oct; 39(5):713-8. PubMed ID: 8645555
    [No Abstract]   [Full Text] [Related]  

  • 2. The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement.
    Nakamura N; Nakamine H; Tamaru J; Nakamura S; Yoshino T; Ohshima K; Abe M
    Mod Pathol; 2002 Jul; 15(7):771-6. PubMed ID: 12118116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
    Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
    Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-MYC impairs immunogenicity of human B cells.
    Schlee M; Schuhmacher M; Hölzel M; Laux G; Bornkamm GW
    Adv Cancer Res; 2007; 97():167-88. PubMed ID: 17419945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homogeneous immunophenotype and paucity of secondary genomic aberrations are distinctive features of endemic but not of sporadic Burkitt's lymphoma and diffuse large B-cell lymphoma with MYC rearrangement.
    Barth TF; Müller S; Pawlita M; Siebert R; Rother JU; Mechtersheimer G; Kitinya J; Bentz M; Möller P
    J Pathol; 2004 Aug; 203(4):940-5. PubMed ID: 15258997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmunity and lymphoma: tribulations of B cells.
    Mackay IR; Rose NR
    Nat Immunol; 2001 Sep; 2(9):793-5. PubMed ID: 11526388
    [No Abstract]   [Full Text] [Related]  

  • 7. Germinal center and activated b-cell profiles separate Burkitt lymphoma and diffuse large B-cell lymphoma in AIDS and non-AIDS cases.
    Gormley RP; Madan R; Dulau AE; Xu D; Tamas EF; Bhattacharyya PK; LeValley A; Xue X; Kumar P; Sparano J; Ramesh KH; Pulijaal V; Cannizzaro L; Walsh D; Ioachim HL; Ratech H
    Am J Clin Pathol; 2005 Nov; 124(5):790-8. PubMed ID: 16203284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EBV-B cell interactions: immortalization, rescue from apoptosis, tumorigenicity (a short review).
    Klein G
    Acta Microbiol Immunol Hung; 1996; 43(2-3):97-105. PubMed ID: 8876725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell development and maturation.
    Rudin CM; Thompson CB
    Semin Oncol; 1998 Aug; 25(4):435-46. PubMed ID: 9728594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor correlation between clonal immunoglobulin gene rearrangement and immunoglobulin gene transcription in Hodgkin's disease.
    Yatabe Y; Oka K; Asai J; Mori N
    Am J Pathol; 1996 Oct; 149(4):1351-61. PubMed ID: 8863682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors in the development of AIDS-related lymphomas.
    Broder S
    Leukemia; 1992; 6 Suppl 3():6S-9S. PubMed ID: 1318478
    [No Abstract]   [Full Text] [Related]  

  • 12. EBV framed in Burkitt lymphoma.
    Speck SH
    Nat Med; 2002 Oct; 8(10):1086-7. PubMed ID: 12357244
    [No Abstract]   [Full Text] [Related]  

  • 13. B cells under influence: transformation of B cells by Epstein-Barr virus.
    Küppers R
    Nat Rev Immunol; 2003 Oct; 3(10):801-12. PubMed ID: 14523386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple phenotypic consequences of the Ig/Myc translocation in B-cell-derived tumors.
    Klein G
    Genes Chromosomes Cancer; 1989 Sep; 1(1):3-8. PubMed ID: 2487145
    [No Abstract]   [Full Text] [Related]  

  • 15. Adhesion molecules, immunosurveillance, and B-cell malignancies.
    Lancet; 1988 Jan; 1(8579):248-9. PubMed ID: 2893077
    [No Abstract]   [Full Text] [Related]  

  • 16. The LCR of EBV makes Burkitt's lymphoma endemic.
    Niller HH; Salamon D; Banati F; Schwarzmann F; Wolf H; Minarovits J
    Trends Microbiol; 2004 Nov; 12(11):495-9. PubMed ID: 15488390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling through the antigen receptor of B lymphocytes activates a p53-independent pathway of c-Myc-induced apoptosis.
    Hagiyama H; Adachi T; Yoshida T; Nomura T; Miyasaka N; Honjo T; Tsubata T
    Oncogene; 1999 Jul; 18(28):4091-8. PubMed ID: 10435590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scavenger receptors mediate adhesion of activated B lymphocytes.
    Yokota T; Ehlin-Henriksson B; Hansson GK
    Exp Cell Res; 1998 Feb; 239(1):16-22. PubMed ID: 9511720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of different polymerase chain reaction-based approaches for clonality assessment of immunoglobulin heavy-chain gene rearrangements in B-cell neoplasia.
    Derksen PW; Langerak AW; Kerkhof E; Wolvers-Tettero IL; Boor PP; Mulder AH; Vrints LW; Coebergh JW; van Krieken JH; Schuuring E; Kluin PM; van Dongen JJ
    Mod Pathol; 1999 Aug; 12(8):794-805. PubMed ID: 10463482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of minimal residual disease in B-lymphoproliferative disorders: a three step SSCP-PCR method.
    Miglino M; Grasso R; Pietrasanta D; Palmisano GL; Berisso G; Clavio M; Pierri I; Santini G; Canepa L; Gobbi M
    J Exp Clin Cancer Res; 2001 Mar; 20(1):95-101. PubMed ID: 11370837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.